Ok before all the Dexcom (NASDAQ: DXCM) stakeholders have a kanipshan, which is Yiddish and means throwing a hissy fit take a deep breath and relax. Everyone knew shares would take a beating today with the approval of the FreeStyle Libre yesterday and it’s better than anticipated label. With this milestone behind Abbott (NYSE: ABT) put a big circle around October 18th as at 8am CST is the start of their third quarter earnings conference call. A call where they will be bombarded with questions on their strategy for getting Libre into the hands of patients and how they . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.